The Cardio Vascular Clinical Trialists Forum (CVCT) serves as a unique think tank, focusing on the latest critical trials in the fields of CardioVascular, CardioRenal, and Cardiometabolic health. It provides a platform for authoritative stakeholders to spend hours delving into individual trials, examining them both individually and in context. The forum aims to foster collaboration, brainstorming, and knowledge-sharing among key clinical trial players.
Richmond Pharmacology will attend JSCPT 2025 in Tokyo, represented by their leadership team. Topics include early-phase studies, bridging studies between Europe and Asia, gene and RNA-based therapy development, and cross-border collaboration.
By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
.svg){kind=small}
.avif)
